These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 31149861)
1. Carbonic anhydrase inhibitors in patients with X-linked retinoschisis: effects on macular morphology and function. Testa F; Di Iorio V; Gallo B; Marchese M; Nesti A; De Rosa G; Melillo P; Simonelli F Ophthalmic Genet; 2019 Jun; 40(3):207-212. PubMed ID: 31149861 [No Abstract] [Full Text] [Related]
2. Efficacy of Carbonic Anhydrase Inhibitors on Cystoid Fluid Collections and Visual Acuity in Patients with X-Linked Retinoschisis. Hensman J; Hahn LC; van Schooneveld MJ; Diederen RMH; Ten Brink JB; Florijn RJ; Bergen AA; Strubbe I; Heutinck P; van Genderen MM; van den Born LI; Thiadens AA; de Zaeytijd J; Leroy BP; Hoyng CB; Boon CJF Ophthalmol Retina; 2024 Jun; 8(6):600-606. PubMed ID: 38104928 [TBL] [Abstract][Full Text] [Related]
3. Carbonic Anhydrase Inhibitors for the Treatment of Cystic Macular Lesions in Children With X-Linked Juvenile Retinoschisis. Verbakel SK; van de Ven JP; Le Blanc LM; Groenewoud JM; de Jong EK; Klevering BJ; Hoyng CB Invest Ophthalmol Vis Sci; 2016 Oct; 57(13):5143-5147. PubMed ID: 27699410 [TBL] [Abstract][Full Text] [Related]
4. STRUCTURAL AND FUNCTIONAL MONITORING OF EXTRAMACULAR CYSTOID SPACES IN A CASE OF X-LINKED RETINOSCHISIS TREATED WITH ACETAZOLAMIDE. Collison FT; Fishman GA Retin Cases Brief Rep; 2018 Fall; 12(4):318-321. PubMed ID: 27984356 [TBL] [Abstract][Full Text] [Related]
5. Treatment of adult-onset acute macular retinoschisis in enhanced s-cone syndrome with oral acetazolamide. Iannaccone A; Fung KH; Eyestone ME; Stone EM Am J Ophthalmol; 2009 Feb; 147(2):307-312.e2. PubMed ID: 18835469 [TBL] [Abstract][Full Text] [Related]
6. Rapid resolution of retinoschisis with acetazolamide. Zhang L; Reyes R; Lee W; Chen CL; Chan L; Sujirakul T; Chang S; Tsang SH Doc Ophthalmol; 2015 Aug; 131(1):63-70. PubMed ID: 25796216 [TBL] [Abstract][Full Text] [Related]
7. Diurnal variations of foveoschisis by optical coherence tomography in patients with RS1 X-linked juvenile retinoschisis. Abalem MF; Musch DC; Birch DG; Pennesi ME; Heckenlively JR; Jayasundera T Ophthalmic Genet; 2018 Aug; 39(4):437-442. PubMed ID: 29902095 [TBL] [Abstract][Full Text] [Related]
8. Carbonic anhydrase inhibitors limit complications in X-linked retinoschisis. Wey S; Brill DA; Miraldi Utz V; Sisk RA Front Med (Lausanne); 2023; 10():1281068. PubMed ID: 38020097 [TBL] [Abstract][Full Text] [Related]
9. USE OF A CARBONIC ANHYDRASE INHIBITOR IN X-LINKED RETINOSCHISIS: Effect on Cystic-Appearing Macular Lesions and Visual Acuity. Andreuzzi P; Fishman GA; Anderson RJ Retina; 2017 Aug; 37(8):1555-1561. PubMed ID: 27828908 [TBL] [Abstract][Full Text] [Related]
10. Prospective Evaluation of Patients With X-Linked Retinoschisis During 18 Months. Pennesi ME; Birch DG; Jayasundera KT; Parker M; Tan O; Gurses-Ozden R; Reichley C; Beasley KN; Yang P; Weleber RG; Bennett LD; Heckenlively JR; Kothapalli K; Chulay JD; For The Xlrs-Study Group Invest Ophthalmol Vis Sci; 2018 Dec; 59(15):5941-5956. PubMed ID: 30551202 [TBL] [Abstract][Full Text] [Related]
11. Retrospective cohort study exploring whether an association exists between spatial distribution of cystoid spaces in cystoid macular oedema secondary to retinitis pigmentosa and response to treatment with carbonic anhydrase inhibitors. Strong SA; Hirji N; Quartilho A; Kalitzeos A; Michaelides M Br J Ophthalmol; 2019 Feb; 103(2):233-237. PubMed ID: 29706600 [TBL] [Abstract][Full Text] [Related]
12. Acetazolamide in the treatment of X-linked retinoschisis maculopathy. Ghajarnia M; Gorin MB Arch Ophthalmol; 2007 Apr; 125(4):571-3. PubMed ID: 17420384 [No Abstract] [Full Text] [Related]
13. Efficacy of sustained topical dorzolamide therapy for cystic macular lesions in patients with X-linked retinoschisis. Genead MA; Fishman GA; Walia S Arch Ophthalmol; 2010 Feb; 128(2):190-7. PubMed ID: 20142541 [TBL] [Abstract][Full Text] [Related]
14. Decreased macular thickness in nonproliferative macular telangiectasia type 2 with oral carbonic anhydrase inhibitors. Chen JJ; Sohn EH; Folk JC; Mahajan VB; Kay CN; Boldt HC; Russell SR Retina; 2014 Jul; 34(7):1400-6. PubMed ID: 24451922 [TBL] [Abstract][Full Text] [Related]
15. A combination of topical and systemic carbonic anhydrase in the treatment of chromosome X-linked retinoschisis. Rocha Cabrera P; Pareja Ríos AC; Cordovés Dorta L; Mantolán Sarmiento C; Serrano García MA Arch Soc Esp Oftalmol; 2014 Aug; 89(8):320-3. PubMed ID: 24269421 [TBL] [Abstract][Full Text] [Related]
16. X-linked juvenile retinoschisis in females and response to carbonic anhydrase inhibitors: case report and review of the literature. Ali S; Seth R Semin Ophthalmol; 2013 Jan; 28(1):50-4. PubMed ID: 23163265 [TBL] [Abstract][Full Text] [Related]
17. The use of carbonic anhydrase inhibitors in the retreatment of cystic macular lesions in retinitis pigmentosa and X-linked retinoschisis. Thobani A; Fishman GA Retina; 2011 Feb; 31(2):312-5. PubMed ID: 20966823 [TBL] [Abstract][Full Text] [Related]
18. Acetazolamide in retinoschisis: a prospective study. Gurbaxani A; Wei M; Succar T; McCluskey PJ; Jamieson RV; Grigg JR Ophthalmology; 2014 Mar; 121(3):802-3.e3. PubMed ID: 24309554 [No Abstract] [Full Text] [Related]
19. Evaluation of focal retinal function using multifocal electroretinography in patients with X-linked retinoschisis. Sen P; Roy R; Maru S; Ravi P Can J Ophthalmol; 2010 Oct; 45(5):509-13. PubMed ID: 20648073 [TBL] [Abstract][Full Text] [Related]
20. Use of dorzolamide for patients with X-linked retinoschisis. Apushkin MA; Fishman GA Retina; 2006 Sep; 26(7):741-5. PubMed ID: 16963845 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]